Given that 70% of human AMLs show high HOXA9 levels [25], we deemed the Hoxa9 overexpression mouse model as being broadly relevant to human leukemia biology, as opposed to MLL-AF9, which does not co-occur with PHF6 mutation in humans. Here, KMT2A is linked to leukemia.